Situation analysis of the national comprehensive cancer control program (2013) in the I. R. Of Iran; assessment and recommendations based on the IAEA imPACT mission

Archives of Iranian Medicine

Volumn 17, Issue 4, 2014, Pages 221-231

  Rouhollahi, Mohammad Reza ^a   Mohagheghi, Mohammad Ali ^a   Mohammadrezai, Narges ^a   Ghiasvand, Reza ^a   Motlagh, Ali Ghanban ^b,c,d   Harirchi, Iraj ^a   Zendehdel, Kazem ^a,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Control; I.R. of Iran; Situational analysis

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER REGISTRY; CANCER RESEARCH; EARLY DIAGNOSIS; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; IRAN; LIKERT SCALE; PROGRAM EVALUATION; SELF EVALUATION; FEMALE; MALE; NEOPLASMS; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PUBLIC HEALTH; REGISTER;

EARLY DETECTION OF CANCER; FEMALE; HEALTH POLICY; HUMANS; IRAN; MALE; NATIONAL HEALTH PROGRAMS; NEOPLASMS; PALLIATIVE CARE; PROGRAM EVALUATION; REGISTRIES;

EID: 84899643175     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Khosravi A, Taylor R Naghavi M, Lopez AD. Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ. 2007; 85: 607-614
2. World Health Organization W. Noncommunicable Diseases (NCD) CountryProfiles20112011.
3. International Agency for Research on Cancer (IARC). G. GLOBOCAN 2008, IARC, Lyon. Available from: URL: http://www-dep.iarc.fr
4. WHO. National Cancer Control Programmes; Policies and managerial guideline. 2nd ed; 2002.
5. Mousavi SM. Comprehensive cancer control program in Iran. Tehran: Ministry ofHealt and Medical Education, Canncer office; 2007.
6. Mousavi SM, Alamolhoda AA, Gouya MM, Lickiss N. Implementation of Comprehensive National Cancer Control Program in Iran: an experience in a developing country. Ann Oncol. 2008; 19: 398 -400.
7. Program of Action for Cancer Therapy (PACT). Available from: URL: http://cancer.iaea.org(Accessed 2003-11-15, 2013)
8. Integrated Missions of PACT (imPACT) Avalilable form: URL: http://cancer.iaea.org/impact.asp (Accessed 2013-15-11, 2013)
9. World Health Organization W. WHO-IAEA National Cancer Control Programmes Core Capacity Self-Assessment Tool. 2011.
10. Zendehdel K, Marzban M, Nahvijou A, Jafari N. Six-fold Difference in the Stomach Cancer Mortality Rate between Northern and Southern Iran. Arch Iran Med. 2012; 15: 741-746.
11. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, So-toudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. IntJ Cancer. 2003; 107: 113-118.
12. Mehrdad R. Health System in Iran. JMAJ. 2009; 52: 69-73.
13. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009; 45: 747-755.
14. Zendehdel K, Taheri A, Nahvijou A, Sedighi Z, Golmahi M, Hajji M, Evaluation of National Cancer Registry of Iran. (the report is available upon request): Cancer Research Center; 2013.
15. Zendehdel K, Sedigh Z, Hassanloo J, Nahvijou A. Audit of a nationwide pathology-based cancer registry in Iran. BCCR. 2011; 2: 7-13.
16. Keshtmand G, Zendehdel K. Fostering Population-Based Cancer Registries in Developing Countries. Basic Clin CancerRes. 2011; 1: 5-13.
17. Sadjadi A, Zahedi M, Moghadam S, Alimohammadain M, Ghor-bani A, Bahmanyar S, Mohagheghi M. A., Malekzadeh R., The First Population Based Survey in Kerman Province of Iran. Iranian J Pub Health. 2007; 36: 26-34.
18. Babaei M, Mousavi S, Malek M, Tosi G, Masoumeh Z, Danaei N, et al. Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev. 2005; 6: 159-164.
19. Mohagheghi MA, Mosavi-Jarrahi A. Cancer Incidence in the Population of Tehran Metropolis 1998-2001. Tehran: Cancer Research Center of Cancer Institute; 2006.
20. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat SM, Nouraie SM, Semnani S, Malekzadeh R. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012 Apr;15(4):196-200.
21. Somi MH, Farhang S, Mirinezhad SK, Naghashi S, Seif-Farshad M, Golzari M. Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev. 2008; 9: 327-330.
22. IARC. Cancer Incidence in Five Continents, Vol. X (electronic version) Lyon, IARC. Available form: URL: http://ci5.iarc.fr last accessed on 01092014 (The printed version of this volume: IARC Scientific Publications No. 164, will be available in 2014.) 2013.
23. dos Santos Silva I. The role of cancer registries. Cancer Epidemiology Principles andMethods. Lyon: Internatoinal Agency for Research on Cancer, 1999: 385-403.
24. Jensen O, Parkin DM, Maclenan R Muir CS, Skeet RG. Cancer Registration: Principles andMethods. Lyon: IARC press; 1991.
25. Aryaie M, Roshandel G, Semnani S, Asadi-Lari M, Aarabi M, Vakili MA, et al. Predictors of colorectal cancer survival in Golestan, Iran: a population-based study. Epidemiol Health. 2013; 35: e2013004.
26. Ghabeljoo M, Jafarabadi MA, Mohammadi SM, Hajizadeh E, Ka-zemnejad A, Fatemi SR. Patterns of survival for anatomical sites of colorectal cancer with shift to advanced lesions in Iran. Asian Pac J Cancer Prev. 2011; 12: 1225-1231.
27. Moradi A, Khayamzadeh M, Guya M, Mirzaei HR, Salmanian R, Rakhsha A, et al. Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev. 2009; 10: 583-586.
28. Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K. Prognostic factors and survival in stomach cancer-analysis of 15 years of data from a referral hospital in iran and evaluation of international variation. Onkologie. 2011; 34: 178-182.
29. Harirchi I, Kolahdoozan S, Hajizadeh S, Safari F, Sedighi Z, Nahvijou A, et al. Esophageal cancer in Iran; a population-based study regarding adequacy of cancer surgery and overall survival. European journal of surgical oncology. Eur J Surg Oncol. 2014; 40: 352-357.
30. Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N, Mohseni SM, Montazeri A, et al. Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol. 2010: 22: 93-97.
31. Mir MR, Rajabpour MV, Delarestaghi MM, Hadji M, Harirchi I, Mir P, et al. Short- and Long-Term Survival of Esophageal Cancer Patients Treated at the Cancer Institute of Iran. Dig Surg. 2013; 30: 331-336.
32. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollah-zadeh D, et al. Survival rate of gastric and esophageal cancers in Ar-dabil province, North-West of Iran. Arch Iran Med. 2007; 10: 32- 37.
33. Sargeran K, Murtomaa H, Safavi S, Teronen O. Delayed diagnosis of oral cancer in Iran: challenge for prevention. Oral Health & Preventive Dentistry. 2009; 7: 69.
34. Zahir ST, Mirtalebi M. Survival of patients with lung cancer, Yazd, Iran. Asian Pac J Cancer Prev. 2012; 13: 4387- 4391.
35. Najafi B, Anvari S, Roshan ZA. Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran. Asian Pac J Cancer Prev. 2013; 14: 5811-5816.
36. Ziaei JE, Sanaat Z, Asvadi I, Dastgiri S, Pourzand A, Vaez J. Survival analysis of breast cancer patients in northwest Iran. Asian Pac J CancerPrev. 2013; 14: 39-42.
37. Movahedi M, Haghighat S, Khayamzadeh M, Moradi A, Ghanbari-Motlagh A, Mirzaei, H, Esmail-Akbari M., Survival rate of breast cancer based on geographical variation in iran, a national study. Iran Red Crescent Med J. 2012; 14: 798-804.
38. Vostakolaei FA, Broeders MJ, Rostami N, van Dijck JA, Feuth T, Kie-meney LA, et al. Age at diagnosis and breast cancer survival in Iran. Int J Breast Cancer. 2012; 2012: 517976.
39. Fouladi N, Amani F, Harghi AS, Nayebyazdi N. Five year survival of women with breast cancer in Ardabil, north-west of Iran. Asian Pac J Cancer Prev. 2011; 12: 1799-1801.
40. Sadjadi A, Hislop TG, Bajdik C, Bashash M, Ghorbani A, Nouraie M, et al. Comparison of breast cancer survival in two populations: Ard-abil, Iran and British Columbia, Canada. BMC Cancer. 2009; 9: 381.
41. Rezaianzadeh A, Peacock J, Reidpath D, Talei A, Hosseini SV, Mehra-bani D. Survival analysis of1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer. 2009; 9: 168.
42. Vahdaninia M, Montazeri A. Breast cancer in Iran: a survival analysis. Asian Pac J Cancer Prev. 2004; 5: 223-225.
43. Mirinezhad SK, Somi MH, Seyednezhad F, Jangjoo AG, Ghojazadeh M, Mohammadzadeh M, et al. Survival in patients treated with definitive chemo- radiotherapy for non-metastatic esophageal cancer in north- west iran. Asian Pac J Cancer Prev. 2013; 14: 1677-1680.
44. Mirinezhad SK, Somi MH, Jangjoo AG, Seyednezhad F, Dastgiri S, Mohammadzadeh M, et al. Survival rate and prognostic factors of esophageal cancer in east Azerbaijan province, North-west of Iran. Asian Pac J Cancer Prev. 2012; 13: 3451-3454.
45. Ghadimi MR, Rasouli M, Mahmoodi M, Mohammad K. Prognostic factors for the survival of patients with esophageal cancer in Northern Iran. Journal of research in medical sciences. J Isfahan Univ Med Sci. 2011; 16: 1261-1272.
46. Taziki MH, Rajaee S, Behnampour N, Tadrisee M, Mansourian AR. Esophageal cancer: 5-year survival rate at south-east of Caspian sea of northern Iran. J Cancer Res Ther. 2011; 7: 135-137.
47. Zare A, Mahmoodi M, Mohammad K, Zeraati H, Hosseini M, Naieni KH. Survival analysis of patients with gastric cancer undergoing surgery at the iran cancer institute: a method based on multi-state models. Asian Pac J Cancer Prev. 2013; 14: 6369-6373.
48. Baghestani AR, Hajizadeh E, Fatemi SR. Bayesian analysis for sur- vival of patients with gastric cancer in Iran. Asian Pac J Cancer Prev. 2009; 10: 823-826.
49. Mehrabian A, Esna-Ashari F, Zham H, Hadizadeh M, Bohlooli M, Khay- amzadeh M, Akbari, ME. Gastric cancer prevalence, according to sur- vival data in iran (national study-2007). Iran J Pub Health. 2010; 39: 27-31.
50. Movahedi M, Afsharfard A, Moradi A, Nasermoaddeli A, Khoshnevis J., Fattahi F, Akbari, ME. Survival rate of gastric cancer in Iran. Journal of research in medical sciences. J Isfahan UnivMedSci. 2009; 14: 367-373.
51. World Health Organization W. Global Action Plan for the Prevention and Control of Non-communicable diseases 2013-2020, Revised Draft. Ver. Date 11 Feb. 2013.
52. Ministry of Health and Medical Edcation IRI. Iran NCD Risk Factors STEPs Report; 2009.
53. Rashidian A, Khosravi A, Khabiri Nemati R, Elahi E, Arab M, Reaei Z. Health Observatory, First Report, I.R. Iran Multiple-Indicators Demographic and Health Survey: National Institue for Health Research, I.R of Iran; 2010.
54. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oe-sophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008; 98: 1857-1863.
55. Adami H-O, Hunter D, Tricoploulos D. Textbook of CancerEpidemiology. First ed. New York: Oxford University Press; 2002.
56. Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ. 2012; 344: e2502.
57. Meysamie A, Sedaghat M, Mahmoodi M, Ghodsi SM, Eftekhar B. Opium use in a rural area of the Islamic Republic of Iran. East Medi-terr Health J. 2009; 15: 425-431.
58. Abdollahifard G, Vakili V, Danaei M, Askarian M, Romito L, Palenik CJ. Are the predictors of hookah smoking differ from those of cigarette smoking? Report of a population-based study in Shiraz, Iran, 2010. Int J Prev Med. 2013; 4: 459-466.
59. Islami F, Pourshams A, Vedanthan R, Poustchi H, Kamangar F, Golo-zar A, et al. Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart. 2013; 99: 272-278.
60. Koul PA, Hajni MR, Sheikh MA, Khan UH, Shah A, Khan Y, et al. Hookah smoking and lung cancer in the Kashmir valley of the Indian subcontinent. Asian Pac J Cancer Prev. 2011; 12: 519-524.
61. Chaouachi K, Sajid KM. Cancer risks of hookah (shisha, narghile) tobacco use require further independent sound studies. Int J Cancer. 2010; 127: 1737-9; author reply 9-40.
62. Chaouachi K, Sajid KM. A critique of recent hypotheses on oral (and lung) cancer induced by water pipe (hookah, shisha, narghile) tobacco smoking. Medical Hypotheses. 2010; 74: 843-846.
63. Regueiro M, Cadenas AM, Gayden T, Underhill PA, Herrera RJ. Iran: tricontinental nexus for Y-chromosome driven migration. Hum Hered. 2006; 61: 132-143.
64. Bleyer A, Welch HG. Effect of three decades of screening mammog-raphy on breast-cancer incidence. N Engl J Med. 2012; 367: 1998-2005.
65. Bell RJ, Burton RC. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no. MedJ Aust. 2012; 196: 17.
66. Breast cancer: prevention and control. Available from: URL: http://www.who.int/cancer/detection/breastcancer/en/. (Accessed 2014-0225, 2014)
67. Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011; 12: 387-398.
68. Yip CH, Cazap E, Anderson BO, Bright KL, Calefli M, Cardoso F, et al. Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast. 2011; (20 suppl 2): S12-S19.
69. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, H Rashidi B, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women-analyses of national data and systematic review of the literature. Gynecol Oncol. 2013; 128: 277-281.
70. Baradaran-Seyed Z, Nedjat S, Yazdizadeh B, Nedjat S, Majdzadeh R. Barriers of clinical practice guidelines development and implementation in developing countries: a case study in iran. International Journal of Preventive Medicine. 2013; 4: 340-348.
71. Greer HO, Frederick PJ, Falls NM, Tapley EB, Samples KL, Kimball KJ, et al. Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies. International journal of gynecological cancer. Int J Gynecol Cancer. 2010; 20: 1321-1325.
72. Purmonen TT, Pankalainen E, Turunen JH, Asseburg C, Martikainen JA. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Onco- logica. 2011; 50: 344-352.